| Primary |
| Hypertension |
42.2% |
| Drug Use For Unknown Indication |
24.3% |
| Essential Hypertension |
8.7% |
| Unevaluable Event |
2.8% |
| Hypotension |
2.3% |
| Diabetes Mellitus |
2.2% |
| Threatened Labour |
2.2% |
| Tocolysis |
1.9% |
| Insomnia |
1.5% |
| Epidural Anaesthesia |
1.3% |
| Gastric Ulcer |
1.3% |
| Benign Prostatic Hyperplasia |
1.2% |
| Hyperuricaemia |
1.2% |
| Maintenance Of Anaesthesia |
1.2% |
| Pregnancy Induced Hypertension |
1.2% |
| Asthma |
1.0% |
| Blood Pressure Increased |
1.0% |
| Suicide Attempt |
1.0% |
| Body Temperature Increased |
0.9% |
| Cerebral Infarction |
0.9% |
|
| Renal Failure Acute |
10.3% |
| Shock |
9.5% |
| Hypotension |
7.1% |
| Liver Disorder |
7.1% |
| Tachycardia |
6.3% |
| Hypertension |
5.6% |
| Rhabdomyolysis |
5.6% |
| Platelet Count Decreased |
4.8% |
| Renal Failure |
4.8% |
| Thrombocytopenia |
4.8% |
| Cerebral Haemorrhage |
4.0% |
| Malaise |
4.0% |
| Toxic Epidermal Necrolysis |
4.0% |
| Agranulocytosis |
3.2% |
| Cerebral Infarction |
3.2% |
| Erythema Multiforme |
3.2% |
| Myocardial Infarction |
3.2% |
| Poor Sucking Reflex |
3.2% |
| Pyrexia |
3.2% |
| Renal Failure Chronic |
3.2% |
|
| Secondary |
| Hypertension |
40.3% |
| Drug Use For Unknown Indication |
9.0% |
| Product Used For Unknown Indication |
9.0% |
| Psoas Abscess |
3.9% |
| Supplementation Therapy |
3.7% |
| Rheumatoid Arthritis |
3.4% |
| Pain |
3.3% |
| Diabetes Mellitus |
3.2% |
| Hyperlipidaemia |
2.9% |
| Essential Hypertension |
2.7% |
| Renal Transplant |
2.6% |
| Self Mutilation |
2.5% |
| Hyperuricaemia |
2.3% |
| Insomnia |
1.7% |
| Prophylaxis |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Angina Pectoris |
1.6% |
| Rectal Cancer |
1.6% |
| Gastritis |
1.5% |
| Hyperglycaemia |
1.5% |
|
| White Blood Cell Count Increased |
10.4% |
| Melaena |
6.9% |
| Hypertension |
6.3% |
| Stevens-johnson Syndrome |
6.3% |
| Agranulocytosis |
5.6% |
| Hypotension |
5.6% |
| Shock |
5.6% |
| Toxic Epidermal Necrolysis |
5.6% |
| Pyrexia |
4.9% |
| Weight Increased |
4.9% |
| Dizziness |
4.2% |
| Osteonecrosis |
4.2% |
| Pruritus |
4.2% |
| Rhabdomyolysis |
4.2% |
| Syncope |
4.2% |
| Hepatic Function Abnormal |
3.5% |
| Liver Disorder |
3.5% |
| Renal Failure Acute |
3.5% |
| Renal Impairment |
3.5% |
| Suicide Attempt |
3.5% |
|
| Concomitant |
| Hypertension |
33.3% |
| Product Used For Unknown Indication |
13.7% |
| Drug Use For Unknown Indication |
12.5% |
| Prophylaxis |
4.7% |
| Rheumatoid Arthritis |
4.3% |
| Diabetes Mellitus |
3.8% |
| Surgery |
2.7% |
| Constipation |
2.5% |
| Pain |
2.5% |
| Angina Pectoris |
2.3% |
| Osteoporosis |
2.2% |
| Gastritis |
2.1% |
| Insomnia |
2.1% |
| Hyperlipidaemia |
2.0% |
| Type 2 Diabetes Mellitus |
1.8% |
| Renal Transplant |
1.6% |
| Multiple Myeloma |
1.6% |
| Abdominal Pain |
1.5% |
| Depression |
1.5% |
| Herpes Zoster |
1.4% |
|
| Vomiting |
13.3% |
| Renal Impairment |
6.8% |
| Renal Failure |
6.1% |
| White Blood Cell Count Decreased |
6.1% |
| Rhabdomyolysis |
6.0% |
| Pyrexia |
5.9% |
| Renal Failure Acute |
5.6% |
| Hypoglycaemia |
5.5% |
| Weight Decreased |
5.0% |
| Myocardial Infarction |
4.7% |
| Death |
4.2% |
| Pneumonia |
4.2% |
| Thrombocytopenia |
4.0% |
| Interstitial Lung Disease |
3.5% |
| Malaise |
3.4% |
| Nausea |
3.4% |
| Renal Failure Chronic |
3.2% |
| Tremor |
3.1% |
| Dyspnoea |
3.0% |
| Loss Of Consciousness |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
39.4% |
| Product Used For Unknown Indication |
11.9% |
| Hypertension |
9.2% |
| Hiv Infection |
7.3% |
| Myocardial Ischaemia |
5.5% |
| Bronchopulmonary Aspergillosis |
2.8% |
| Epilepsy |
2.8% |
| Peptic Ulcer |
2.8% |
| Raynaud's Phenomenon |
2.8% |
| Crest Syndrome |
1.8% |
| Diabetes Mellitus |
1.8% |
| Gastritis |
1.8% |
| Hypercalcaemia |
1.8% |
| Hyperlipidaemia |
1.8% |
| Nail Tinea |
1.8% |
| Arthritis |
0.9% |
| Atrial Fibrillation |
0.9% |
| Atrial Flutter |
0.9% |
| Benign Prostatic Hyperplasia |
0.9% |
| Essential Hypertension |
0.9% |
|
| Hypotension |
14.3% |
| Pyrexia |
14.3% |
| Drug Interaction |
9.5% |
| Melaena |
9.5% |
| Oedema Peripheral |
9.5% |
| Hypertensive Crisis |
4.8% |
| Malaise |
4.8% |
| Movement Disorder |
4.8% |
| Neutropenia |
4.8% |
| Pleural Effusion |
4.8% |
| Presyncope |
4.8% |
| Sinus Bradycardia |
4.8% |
| Status Epilepticus |
4.8% |
| Vascular Encephalopathy |
4.8% |
|
